Cash and Cash Equivalents, at Carrying Value of 10x Genomics, Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
10x Genomics, Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • 10x Genomics, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2024 was $344,067,000, a 4.2% decline year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

10x Genomics, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $344,067,000 -$15,217,000 -4.2% 31 Dec 2024 10-K 13 Feb 2025 2024 FY
Q4 2023 $359,284,000 +$139,538,000 +64% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q4 2022 $219,746,000 -$367,701,000 -63% 31 Dec 2022 10-K 13 Feb 2025 2024 FY
Q4 2021 $587,447,000 -$76,156,000 -11% 31 Dec 2021 10-K 15 Feb 2024 2023 FY
Q4 2020 $663,603,000 +$239,437,000 +56% 31 Dec 2020 10-K 16 Feb 2023 2022 FY
Q4 2019 $424,166,000 +$359,086,000 +552% 31 Dec 2019 10-K 18 Feb 2022 2021 FY
Q3 2019 $427,436,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q4 2018 $65,080,000 +$17,223,000 +36% 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q4 2017 $47,857,000 31 Dec 2017 10-K 27 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.